Arena Pharmaceuticals Granted Patent for Drug Screening Methods Related to Ortho McNeil, Inc. Collaboration
15-Aug-2005 -
Arena Pharmaceuticals, Inc. announced that it was granted patent number 1133559, entitled "HUMAN ORPHAN G PROTEIN-COUPLED RECEPTOR RUP3," by the European Patent Office. The patent relates to certain drug screening methods utilizing the 19AJ receptor, an orphan G protein-coupled receptor, or GPCR, ...
drug development
drug screening
G-proteins
+3